-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Oleclumab in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Oleclumab in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Oleclumab in Solid Tumor Drug Details: Oleclumab (MEDI-9447) is under development...
-
Product Insights
NewInfluenzavirus B Infections – Drugs In Development, 2024
Empower your strategies with our Influenzavirus B Infections – Drugs In Development, 2024 report and make more profitable business decisions. Type B influenza is a subtype of the influenza virus that tends to occur sporadically. Symptoms include runny nose, sore throat, aching muscles, malaise, watery eyes, aching body, loss of appetite, and weakness. Treatment includes antivirals, analgesics, and antipyretics medications. The Influenzavirus B Infections drugs in development market research report provide comprehensive information on the therapeutics under development for Influenzavirus B...
-
Product Insights
NewInfluenzavirus A Infections – Drugs In Development, 2024
Empower your strategies with our Influenzavirus A Infections – Drugs In Development, 2024 report and make more profitable business decisions. Influenza A virus infections are caused by a type of influenza virus with a high capacity for genetic variation. It is more serious than the common cold and can cause major outbreaks and severe disease. It spreads through droplets from the nose or throat of an infected person, usually through coughing and sneezing. The proteins on the surface of the influenza...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CR-9114 in Influenzavirus B Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CR-9114 in Influenzavirus B Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.CR-9114 in Influenzavirus B InfectionsDrug Details:CR-9114 is under development for the protection...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CR-9114 in Influenzavirus A Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CR-9114 in Influenzavirus A Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.CR-9114 in Influenzavirus A InfectionsDrug Details:CR-9114 is under development for the protection...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zanidatamab Zovodotin in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zanidatamab Zovodotin in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Zanidatamab Zovodotin in Solid Tumor Drug Details:Zanidatamab Zovodotin is under development for the...
-
Product Insights
Transmucosal Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Transmucosal Drug Delivery Pipeline Market Report Overview A Transmucosal drug delivery device is intended for the localized delivery of medications through a mucous membrane. The transmucosal drug delivery pipeline market research report provides comprehensive information about the transmucosal drug delivery pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segment ·      Nasal ·      Vaginal ·      Buccal Delivery ·      Rectal Key Territories ·      The US...